Sign-in to Ask A Doctor - 24x7
OR
Sign in with GoogleGet your health question answered instantly from our pool of 18000+ doctors from over 80 specialties
What Causes Shortness Of Breath After Insertion Of Stents In The Heart?
a friend of mine had 2 sents put in last week . He is 75 years old and has 5 stents previously. he was taking brilinta 90mg but he stopped due to excessive bleeding. he is also onenoxaparin sodium injection 80 mg twice a day in his belly one in morning on one side and one in evening on other side. he has slight shortness of breath.
Mon, 19 Dec 2016
hi and very pleased to answer you
The dyspnea (shortness of breath) reported by your friend is related the use of brilinta 90mg (TICAGRELOR a potent oral inhibitor of platelet activity). Dyspnea has been reported in patients treated with ticagrelor. Dyspnea are generally mild to moderate in intensity and often resolve without the need to discontinue treatment.
Patients with asthma / chronic obstructive pulmonary disease (COPD) may have an increased absolute risk of dyspnea under ticagrelor. Ticagrelor should be used with caution in patients with a history of asthma and / or COPD. The mechanism has not been elucidated. If a patient develops a new, prolonged or aggravated dyspnea, a complete exploration is necessary and if this is poorly tolerated, treatment with ticagrelor should be discontinued. shortness of breath disappears in the majority of cases during the first week of treatment.
best wishes
The dyspnea (shortness of breath) reported by your friend is related the use of brilinta 90mg (TICAGRELOR a potent oral inhibitor of platelet activity). Dyspnea has been reported in patients treated with ticagrelor. Dyspnea are generally mild to moderate in intensity and often resolve without the need to discontinue treatment.
Patients with asthma / chronic obstructive pulmonary disease (COPD) may have an increased absolute risk of dyspnea under ticagrelor. Ticagrelor should be used with caution in patients with a history of asthma and / or COPD. The mechanism has not been elucidated. If a patient develops a new, prolonged or aggravated dyspnea, a complete exploration is necessary and if this is poorly tolerated, treatment with ticagrelor should be discontinued. shortness of breath disappears in the majority of cases during the first week of treatment.
best wishes
I find this answer helpful
Disclaimer: These answers are for your information only and not intended to replace your relationship with your treating physician.
This is a short, free answer.
For a more detailed, immediate answer, try our premium service
[Sample answer]
Related questions you may be interested in
Loading Online Doctors....